PRRT2 and colorectal cancer: PKC-delta (PKCδ), the PKC isozyme, has been demonstrated to be an upstream modulator of NF-κB which can promote the expression of NF-κB-mediated anti-apoptotic oncogenes cIAP-2 and C-FLIP in colorectal cancer cells [16,31].